다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of psychiatric research, v.52, 2014년, pp.7 - 14
Stewart, J.W. , McGrath, P.J. , Blondeau, C. , Deliyannides, D.A. , Hellerstein, D. , Norris, S. , Amat, J. , Pilowsky, D.J. , Tessier, P. , Laberge, L. , O'Shea, D. , Chen, Y. , Withers, A. , Bergeron, R. , Blier, P.
AI-Helper
Introduction: Only about a third of patients with an episode of major depressive disorder remit with a given treatment and few remissions occur within the first weeks of treatment. This study tested whether combining escitalopram and bupropion as initial treatment would result in quicker remission a...
Depression Andrews 4 48 1996 10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B Venlafaxine: a novel antidepressant that has a dual mechanism of action
J Clin Psychiatry Ascher 56 395 1995 Bupropion: a review of its mechanism of antidepressant activity
Eur Neuropsychopharmacol Blier 19 457 2009 10.1016/j.euroneuro.2009.01.015 Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation
Am J Psychiatry Blier 167 281 2010 10.1176/appi.ajp.2009.09020186 Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study
Int J Psychiatry in Clin Pract Bræstrup 8 11 2004 10.1080/13651500410005496 Escitalopram: a unique mechanism of action
Cozza 216 2001 Concise guide to the cytochrome P450 system: drug interaction principles for medical practice
Psychopharmacol Bull Derivan 31 439 1995 Venlafaxine: measuring the onset of antidepressant action
First 2002 User's guide for the structured clinical interview for DSM-IV Axis I disorders (SCID-I)
218 1976 ECDEU Assessment manual for psychopharmacology: publication ADM 76-338
J Neurol Neurosurg Psychiatry Hamilton 23 56 1960 10.1136/jnnp.23.1.56 A rating scale for depression
J Affect Disord Henkel 115 439 2009 10.1016/j.jad.2008.10.011 Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression?
N Engl J Med Hordern 292 1159 1965 10.1056/NEJM196506032722206 The antidepressant drugs
Int Clin Psychopharmacol Kasper 21 105 2006 10.1097/01.yic.0000194375.42589.c3 Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis
Pharmacol Rev Klerman 17 101 1965 Clinical pharmacology of imipramine and related antidepressant compounds
J Psychiatr Pract Leuchter 14 271 2008 10.1097/01.pra.0000336754.19566.65 An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder
Psychopharmacol Bull Levine 22 343 1986 SAFTEE: a technique for the systematic assessment of side effects in clinical trials
Br J Psychiatry Mitchell 188 105 2006 10.1192/bjp.bp.105.011692 Two-week delay in onset of action of antidepressants: new evidence
Br J Psychiatry Montgomery 134 382 1979 10.1192/bjp.134.4.382 A new depression scale designed to be sensitive to change
Arch Gen Psychiatry Nelson 48 303 1991 10.1001/archpsyc.1991.01810280019002 A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression
Biol Psychiatry Nelson 55 296 2004 10.1016/j.biopsych.2003.08.007 Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study
J Clin Psychopharmacol Papakostas 26 56 2006 10.1097/01.jcp.0000195042.62724.76 A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder
Psychiatry Res Papakostas 149 195 2007 10.1016/j.psychres.2006.03.014 Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder
J Clin Psychiatry Posternak 66 148 2005 10.4088/JCP.v66n0201 Is there a delay in the antidepressant effect? A meta-analysis
Arch Gen Psychiatry Quitkin 44 259 1987 10.1001/archpsyc.1987.01800150071009 Use of pattern analysis to identify true drug response: a replication
Biol Psychiatry Rush 54 573 2003 10.1016/S0006-3223(02)01866-8 The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
Am J Psychiatry Rush 168 689 2011 10.1176/appi.ajp.2011.10111645 Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study
Eur Neuropsychopharmacol Stassen 3 127 1993 10.1016/0924-977X(93)90264-M Time course of improvement under antidepressant treatment: a survival-analytical approach
J Psychiatr Pract Stewart 15 337 2009 10.1097/01.pra.0000361276.88339.44 Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Pharmacotherapy Stimmel 17 10 1997 10.1002/j.1875-9114.1997.tb03674.x Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects
J Clin Psychiatry Szegedi 70 344 2009 10.4088/JCP.07m03780 Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients
Hum Psychopharmacol Clin Exp Thompson 17 Suppl. 1 S27 2002 10.1002/hup.386 Onset of action of antidepressants: results of different analyses
Am J Psychiatry Trivedi 163 28 2006 10.1176/appi.ajp.163.1.28 STAR*D study team: evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.